Adrianna England New Director of Inside Sales at Advanced Ultrasound Systems

Adrianna England will be responsible for developing and managing relationships with medical facilities, asset managers, ISO’s and ultrasound dealers.

Adrianna England will capitalize on the company’s long history of success in the ultrasound arena and be responsible for cultivating strong relationships with the medical end user and dealer community. She will report directly to John Hryshchuk, President and CEO at AUS.

England’s appointment comes 15 months after the company’s rebranding announcement from AUE to AUS in December 2020.  The rebrand was to better reflect their emphasis on complete care and serving the needs of clinics and healthcare facilities nationwide.

When a customer purchases a system, the company provides a ‘white glove’, plug-and-play experience and uniquely becomes the customer’s service and parts provider from day one of their warranty as well as post-warranty service provider.  In this way, AUS is a comparable choice to the OEM at a fraction of the cost.

“As a top-ranked vendor and supplier to dealers in the healthcare industry, we needed to bolster stronger relationships with end users to bring them complete ultrasound care across multiple brands,” says Hryshchuk.  “With the addition of Adrianna, we will continue take the reputation gained under our AUE name and offer it as AUS to those using ultrasound day in and day out needing parts, probes, probe repair, portable repair, service, and training.”

With over 20 years of sales experience, England has developed strong sales and account management leadership. Throughout her career, England has created strong relationships that increased revenue for the enterprises she has worked for. Prior to joining the AUS team, England served as Account Executive, National Accounts for Probo Medical and Inside Sales Manager at Conquest Imaging.

“The landscape has changed in the last several years, making it difficult to find a company like AUS who focuses only on ultrasound and provides the customer with everything they need throughout the life of their ultrasound investment,” stated England.  “I believe that doing what’s right for the customer is never wrong.  For over a decade I’ve focused on what the customer needs and giving them the highest level of responsive customer care.  With AUS’s reputation in the industry and their ISO 13485 status, I can continue to sell high-demand quality parts, probes, and repairs to the industry.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.